The Hackstronauts would like to welcome Dylan Beynon for an exciting presentation on the neuroscience of ketamine and its therapeutic applications. Dylan is the Founder & CEO of Mindbloom (www.mindbloom.co), an NYC-based mental health and wellbeing startup helping people expand their human potential with clinician-prescribed, guided psychedelic medicine experiences. There, he is partnering with clinicians, technologists, researchers, and patients to increase access to science-backed treatments, starting by lowering the cost of ketamine therapy for depression and anxiety by over 70%.
Dylan is a 10-year psychedelic medicine patient and 3-time tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton School at The University of Pennsylvania.
Schedule:
7:00 – 7:10 Introduction
7:10 – 7:40 Dylan’s Presentation
7:40 – 8:00 Q&A